A detailed history of Cherry Creek Investment Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cherry Creek Investment Advisors, Inc. holds 5,620 shares of MRK stock, worth $547,612. This represents 0.34% of its overall portfolio holdings.

Number of Shares
5,620
Previous 5,708 1.54%
Holding current value
$547,612
Previous $706,000 9.63%
% of portfolio
0.34%
Previous 0.38%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$111.15 - $128.97 $9,781 - $11,349
-88 Reduced 1.54%
5,620 $638,000
Q2 2024

Jul 17, 2024

SELL
$123.8 - $132.96 $8,047 - $8,642
-65 Reduced 1.13%
5,708 $706,000
Q1 2024

Apr 23, 2024

SELL
$113.24 - $131.95 $19,137 - $22,299
-169 Reduced 2.84%
5,773 $761,000
Q4 2023

Jan 26, 2024

BUY
$100.18 - $109.02 $2,704 - $2,943
27 Added 0.46%
5,942 $647,000
Q3 2023

Oct 13, 2023

SELL
$102.95 - $114.33 $617 - $685
-6 Reduced 0.1%
5,915 $608,000
Q2 2023

Jul 14, 2023

BUY
$108.61 - $118.38 $2,606 - $2,841
24 Added 0.41%
5,921 $683,000
Q1 2023

Apr 24, 2023

BUY
$102.94 - $114.86 $2,470 - $2,756
24 Added 0.41%
5,897 $627,000
Q4 2022

Feb 10, 2023

SELL
$87.44 - $112.11 $4,459 - $5,717
-51 Reduced 0.86%
5,873 $651,000
Q3 2022

Oct 24, 2022

BUY
$84.53 - $94.96 $6,001 - $6,742
71 Added 1.21%
5,924 $510,000
Q2 2022

Jul 20, 2022

BUY
$83.49 - $94.64 $166 - $189
2 Added 0.03%
5,853 $534,000
Q1 2022

Apr 22, 2022

BUY
$73.51 - $82.4 $39,915 - $44,743
543 Added 10.23%
5,851 $480,000
Q4 2021

Feb 11, 2022

BUY
$72.28 - $90.54 $165,159 - $206,883
2,285 Added 75.59%
5,308 $407,000
Q3 2021

Nov 01, 2021

SELL
$71.68 - $78.83 $7,669 - $8,434
-107 Reduced 3.42%
3,023 $227,000
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $220,070 - $243,420
3,130 New
3,130 $243,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Cherry Creek Investment Advisors, Inc. Portfolio

Follow Cherry Creek Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cherry Creek Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cherry Creek Investment Advisors, Inc. with notifications on news.